Assessing the Cardiometabolic Effects of DAPA in Acute MI Patients

The speakers analyze the results of the DAPA MI trial, discussing the cardiometabolic effects of adding DAPA to patients without diabetes or chronic heart failure. They explore the implications of these findings and the potential use of DAPA in patients without an indication.